BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25324451)

  • 1. Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Ploner F; Stojakovic T; Gary T; Leithner A; Pichler M
    Clin Chem Lab Med; 2015 Feb; 53(3):493-7. PubMed ID: 25324451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
    Szkandera J; Pichler M; Liegl-Atzwanger B; Absenger G; Stotz M; Ploner F; Stojakovic T; Samonigg H; Eberhard K; Leithner A; Gerger A
    J Surg Oncol; 2014 Feb; 109(2):139-44. PubMed ID: 24122271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Absenger G; Stotz M; Friesenbichler J; Trajanoski S; Stojakovic T; Eberhard K; Leithner A; Pichler M
    Int J Cancer; 2014 Jul; 135(2):362-70. PubMed ID: 24347236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma.
    Liang Y; Wang W; Que Y; Guan Y; Xiao W; Fang C; Zhang X; Zhou Z
    BMC Cancer; 2018 Oct; 18(1):942. PubMed ID: 30285656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid and the incidence of CKD and hypertension.
    Kuriyama S; Maruyama Y; Nishio S; Takahashi Y; Kidoguchi S; Kobayashi C; Takahashi D; Sugano N; Hosoya T; Yokoo T
    Clin Exp Nephrol; 2015 Dec; 19(6):1127-34. PubMed ID: 25967597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.
    Rob D; Marek J; Dostálová G; Goláň L; Linhart A
    PLoS One; 2016; 11(11):e0166290. PubMed ID: 27835692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Ploner F; Stojakovic T; Leithner A; Pichler M
    PLoS One; 2014; 9(9):e107297. PubMed ID: 25207808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Friesenbichler J; Stojakovic T; Leithner A; Pichler M
    Am J Surg; 2015 Jul; 210(1):111-6. PubMed ID: 25586599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
    Ndrepepa G; Braun S; King L; Cassese S; Tada T; Fusaro M; Hadamitzky M; Haase HU; Schömig A; Kastrati A
    Clin Sci (Lond); 2013 Feb; 124(4):259-68. PubMed ID: 22974091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
    Szkandera J; Absenger G; Liegl-Atzwanger B; Pichler M; Stotz M; Samonigg H; Glehr M; Zacherl M; Stojakovic T; Gerger A; Leithner A
    Br J Cancer; 2013 Apr; 108(8):1677-83. PubMed ID: 23558897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment Serum Uric Acid as an Efficient Predictor of Prognosis in Men with Laryngeal Squamous Cell Cancer: A Retrospective Cohort Study.
    Hsueh CY; Shao M; Cao W; Li S; Zhou L
    Oxid Med Cell Longev; 2019; 2019():1821969. PubMed ID: 31178950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the independent association of uric acid levels with peripheral arterial disease in Chinese patients with coronary heart disease].
    Zheng LQ; Li J; Yu JM; Hasimu B; Hu DY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Feb; 27(2):161-4. PubMed ID: 16750001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
    Stotz M; Szkandera J; Seidel J; Stojakovic T; Samonigg H; Reitz D; Gary T; Kornprat P; Schaberl-Moser R; Hoefler G; Gerger A; Pichler M
    PLoS One; 2014; 9(8):e104730. PubMed ID: 25133546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Absenger G; Stotz M; Samonigg H; Maurer-Ertl W; Stojakovic T; Ploner F; Leithner A; Pichler M
    Br J Cancer; 2013 Oct; 109(9):2316-22. PubMed ID: 24084772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the prognostic value of uric acid on the efficacy of immunotherapy in patients with primary liver cancer.
    Rao H; Wang Q; Zeng X; Wen X; Huang L
    Clin Transl Oncol; 2024 Mar; 26(3):774-785. PubMed ID: 37646984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
    Gotsman I; Keren A; Lotan C; Zwas DR
    J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
    Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
    Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid: novel prognostic factor in primary systemic amyloidosis.
    Kumar S; Dispenzieri A; Lacy MQ; Hayman SR; Leung N; Zeldenrust SR; Buadi FK; Kyle RA; Rajkumar SV; Gertz MA
    Mayo Clin Proc; 2008 Mar; 83(3):297-303. PubMed ID: 18315995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
    Stelzl A; Aziz F; Riedl JM; Posch F; Smolle MA; Stojakovic T; Terbuch A; Pichler M; Bergovec M; Leithner A; Liegl-Atzwanger B; Stotz M; Gerger A; Sourij H; Szkandera J
    Sci Rep; 2020 Jul; 10(1):12438. PubMed ID: 32709908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.